US Patent Issued to BioNTech US, Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhis on March 25 for "T cell manufacturing compositions and methods" (Dutch, American Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,581, issued on March 25, was assigned to BioNTech US Inc. (Cambridge, Mass.) and Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhis (Amsterdam).

"T cell manufacturing compositions and methods" was invented by Marit M. Van Buuren (Belmont, Mass.), Divya Reddy Lenkala (Watertown, Mass.), Joost Huibert Van Den Burg (Amsterdam), Jessica Kohler (Boston), Matthew Goldstein (Jamaica Plain, Mass.), Ed Fritsch (Concord, Mass.), Renate De Boer (Diemen, Netherlands), Ton Schumacher (Aloemehomal, Netherlands) and Noor Bakker (Stuyvesantstraat, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The generation of antigen specific ...